Effect of Ashwabaladi Ghrita Nasya and Anu Tail Nasya in the Management of Vataja Pratishyaya (Allergic Rhinitis)
- Conditions
- Allergic rhinitis, unspecified. Ayurveda Condition: VATAJAPRATISYAYAH,
- Registration Number
- CTRI/2025/06/089198
- Lead Sponsor
- DrMegha Tidke
- Brief Summary
This study aims to evaluate and compare the efficacy of *Ashwabaladi Ghrita Nasya* and *Anu Taila Nasya* in managing Vataja Pratishyaya Allergic Rhinitis It is a randomized controlled clinical trial involving 104 participants aged 20–60 years, divided equally into two groups The intervention group receives Ashwabaladi Ghrita Nasya, and the control group receives Anu Taila Nasya. The trial assesses outcomes like Total Nasal Symptom Score (TNSS), IgE AEC levels and quality of life using the RQLQ scale Ashwabaladi Ghrita with its immunomodulatory and Vata shamaka properties is expected to provide better symptomatic relief The study duration is 10 weeks with a follow up on the 90th day If successful it may offer a safer natural alternative to conventional steroidal treatments.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 104
Aged between 20to 60 years Diagnosed as a case of Vataja Pratishyaya Allergic Rhinitis ICD 10 code J 30.9 will be selected irrespective of gender occupation and socio-economic status Patients who complained of Allergic Rhinitis for more than 6 months Patients who are fit for Nasya karma Nasyarha Only those patients are willing to give informed consent.
Individuals suffering from additional allergy conditions such bronchial asthma or allergic purpura with nasal conchae DNS and nasal polyps Individuals who are allergic to heterologous proteins Individuals receiving steroid treatment Suffering from additional biological conditions such AIDS vascular malformations hypertension diabetes mellitus hematologic abnormalities malignant tumors or mental illnesses Rajaswala pregnant women women who were ready to conceive during the last six months and nursing mothers Patients for whom Nasya is contraindicated.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in IgE level Total Nasal Symptom Score TNSS 12 Weeks
- Secondary Outcome Measures
Name Time Method Rhinoconjunctivitis Quality of Life Questionnaire RQLQ Decrease in IgE level AEC Absolute Eosinophil Count
Trial Locations
- Locations (1)
Mahatma Gandhi Ayurveda College, hospital and Research Centre salod wardha,Maharashtra,India 442001
🇮🇳Wardha, MAHARASHTRA, India
Mahatma Gandhi Ayurveda College, hospital and Research Centre salod wardha,Maharashtra,India 442001🇮🇳Wardha, MAHARASHTRA, IndiaDrMegha TidkePrincipal investigator8329011170drpramodborghare@hotmail.com